Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Companies / Vitestro
Entity

Vitestro

Tracked across 1 events · 7 articles · First seen Aug 19, 2026 · Last active Aug 20, 2026

Sentiment
80
Attention
4
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
Events (1)
4 80
Regulatory
FDA Authorizes Aletta Robotic Blood Draw Device
The U.S. United States — Food and Drug Administration (FDA) has granted marketing authorization to Vitestro for the Aletta, the first standalone robotic device capable of drawing blood from a patient's arm without hands-on operator…
Impact: Vitestro received FDA marketing authorization for its Aletta robotic blood draw device, a first-of-its-kind approval. This milestone validates its technology, potentially boosting its market position and attracting investment, though the company is not publicly traded.
Aug 19, 2026 · 7 articles
Key Actions (1)
100 United States — Food and Drug Administration authorized VitestroFDA Authorizes Aletta...
ERGEN INTELLIGENCE
Track Vitestro live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.